No categories for this tab

About Us

About PharmaCountry
How It Works
Partnerships
Sustainability
Contact Us

For Buyers

Search Products
Search Services
Find Suppliers
Find Jobs
Find Seekers
Help Center
FAQ
Buyer Protection

For Sellers/Service Providers

Start Selling
Seller Guide
Pricing Plans
Advertising
Seller Support

Top Categories

Active Pharmaceutical Ingredients (APIs)
Finished Dosage Forms
Manufacturing Equipment & Utilities
Excipients & Additives
View All Categories

Stay Connected

[email protected]

24/7 Customer Support

Trusted B2B Platform

SSL Secure Transactions Verified Suppliers Quality Assured B2B Certified Global Network

© 2026 PharmaCountry. All rights reserved.

Privacy Policy Terms of Service Cookie Policy

Công ty TNHH MTV Dược Sài Gòn (Sapharco) | Pharmacountry

Companies
Công ty TNHH MTV Dược Sài Gòn (Sapharco)

CT

Công ty TNHH MTV Dược Sài Gòn (Sapharco)

Marketing Authorization Holder · Finished Dosage FormsViet Nam

About Company

Legal Name: Công ty TNHH MTV Dược Sài Gòn (Sapharco)
Registered country: Viet Nam
Address: 18-20 Nguyễn Trường Tộ, Quận 4, TP. Hồ Chí Minh

Business Activities

Finished Dosage Forms

Marketing Authorization Holder

Our Products & Services

Sell · Finished Dosage Forms

DBL Pethidine Hydrochloride 100mg/2ml

Công ty TNHH MTV Dược Sài Gòn (Sapharco)

DBL Pethidine Hydrochloride 100mg/2ml

Pethidine hydrochloridePethidine hydrochloride

Manufacturer: Siegfried Hameln GmbH, Germany

Sell · Finished Dosage Forms

DBL Fentanyl 500mcg/10ml (as citrate) injection

Công ty TNHH MTV Dược Sài Gòn (Sapharco)

DBL Fentanyl 500mcg/10ml (as citrate) injection

Fentanyl CitrateFentanyl citrate

Manufacturer: Siegfried Hameln GmbH, Germany

Sell · Finished Dosage Forms

DBL Fentanyl 100mcg/2ml (as citrate) injection

Công ty TNHH MTV Dược Sài Gòn (Sapharco)

DBL Fentanyl 100mcg/2ml (as citrate) injection

Fentanyl CitrateFentanyl citrate

Manufacturer: Siegfried Hameln GmbH, Germany

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.